Myriad, Stone Brewing, Thorntons: Intellectual Property

Myriad Genetics Inc., the biggest maker of genetic tests for hereditary breast and ovarian cancer, was denied a request for expedited review of an adverse patent decision.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.